Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma

Cancer Research

Volumn 56, Issue 19, 1996, Pages 4297-4301

  Lee, Wen Ching ^a   Balsara, Binaifer ^a   Liu, Zemin ^a   Jhanwar, Suresh C ^b   Testa, Joseph R ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOMAL LOCALIZATION; CHROMOSOME 1P; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; DNA POLYMORPHISM; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENE MAPPING; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPING; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL; TANDEM REPEAT; TUMOR SUPPRESSOR GENE;

CHROMOSOMES, HUMAN, PAIR 1; HUMANS; IN SITU HYBRIDIZATION; MESOTHELIOMA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SACCHAROMYCES CEREVISIAE; SEQUENCE DELETION;

EID: 0029745071     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Solomon, E., Borrow, J., and Goddard, A D Chromosome aberrations and cancer. Science (Washington DC), 254 1153-1160, 1991.
2. Tiainen, M., Tammilehto, L., Mattson, K , and Knuutila, S Non-random chromosomal abnormalities in malignant pleural mesothelioma. Cancer Genet. Cytogenet., 33: 251-274, 1988.
3. Hagemeijer, A., Versnel, M. A., Van Drunen, E., Moret, M., Bouts, M. J., van der Kwast, T. H., and Hoogsteden, H. C. Cytogenetic analysis of malignant mesothelioma. Cancer Genet. Cytogenet, 47: 1-28, 1990.
4. Taguchi, T., Jhanwar, S. C , Siegfried, J. M., Keller, S. M., and Testa, J R. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res., 53: 4349-4355, 1993.
5. Lu, Y. Y., Jhanwar, S. C., Cheng, J. Q., and Testa, J. R. Deletion mapping of the short arm of chromosome 3 in human malignant mesothelioma. Genes Chromosomes Cancer, 9: 76-80, 1994.
6. Cheng, J. Q., Jhanwar, S. C., Lu, Y Y., and Testa, J. R Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesothelioma. Cancer Res., 53: 4761-4763, 1993.
7. Cheng, J. Q., Jhanwar, S C., Klein, W. M., Bell, D. W., Lee, W-C., Altomare, D A , Nobori, T., Olopade, O. I , Buckler, A. J., and Testa, J R. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res., 54: 5547-5551, 1994.
8. Sekido, Y , Pass, H. I., Bader, S . Mew, D. J Y., Christman, M. F., Gazdar, A. F., and Minna, J D Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res , 55: 1227-1231, 1995.
9. Bianchi, A B., Mitsunaga, S-I., Cheng, J. Q., Klein, W M , Jhanwar, S C., Seizinger, B , Kley, N., Klein-Szanto, A J. P., and Testa, J R High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc. Natl. Acad. Sci. USA, 92: 10854-10858, 1995.
10. Antman, K. H , Li, F. P., Osteen, R , and Sugarbaker, D. J. Mesothelioma. In: V T. DeVita, S. Hellman, and S. Rosenberg (eds ), Update, Cancer Principles and Practice, Vol 3, pp. 1-16 Philadelphia J P. Lippincott Co., 1989
11. Ikeuchi, T. Inhibitory effect of ethidium bromide on mitotic chromosome condensation and its application to high-resolution chromosome banding. Cytogenet. Cell Genet., 38: 56-61, 1984.
12. Altomare, D. A., Kozak, C. A., Sonoda, G., and Testa, J. R. Chromosomal mapping of the mouse Akt2 gene and Akt2 pseudogene. Cytogenet. Cell Genet., in press, 1996.
13. Buetow, K. H., Weber, J. L., Ludwigsen, S., Scherpbier-Heddema, T., Duyk, G M, Scheffield, V. C., Wang, Z., and Murray, J. C Integrated human genome-wide maps constructed using the CEPH reference panel Nat. Genet., 6: 391-393, 1994.
14. Gyapay, G , Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M., and Weissenbach, J The 1993-94 Genethon human genetic linkage map Nat Genet., 7: 246-339, 1994.
15. Dib, C., Faure, S., Fizames, C., Samson, D., Drouot, N . Vignal, A., Millasseau, P, Marc, S , Hazan, J., Seboun, E., Lathrop, M., Gyapay, G., Morissette, J., and Weissenbach, J. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (Lond ), 380: 152-154 1996
16. Dracopoli, N. C., Bruns, G. A P., Brodeur, G M , Landes, G. M., Matise, T. C., Seldin, M. F , Vance, J M., and Weith, A. Report of the first international workshop on human chromosome 1 mapping, 1994 Cytogenet Cell Genet , 67: 144-165, 1994
17. Mathew, H., Murty, V. V V. S., Bosl, G J., and Chaganti, R S. K. Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer Res., 54: 6265-6269, 1994.
18. Chen, H-L., Chen, Y-C , and Chen, D-S. Chromosome 1p aberrations are frequent in human primary hepatocellular carcinoma Cancer Genet. Cytogenet , 86: 102-106, 1996
19. Hoggard, N, Brintnell, B., Howell, A., Weissenbach, J, and Varley, J. Allelic imbalance on chromosome 1 in human breast cancer II. Microsatellite repeat analysis Genes Chromosomes Cancer, 12: 24-31, 1995
20. Nagai, H., Negrini, M , Carter, S L., Gillum, D R. Rosenberg, A. L., Schwartz, G F., and Croce, C. M. Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. Cancer Res., 55: 1752-1757, 1995.
21. Cote, R. J , Jhanwar, S C., Novick, S , and Pellicer, A. Genetic alterations of the p53 gene are a feature of malignant mesothelioma. Cancer Res , 51: 5410-5416, 1991.
22. Park, S , Schalling, M , Bernard, A., Maheswaran, S , Shipley, G C., Roberts, D., Fletcher, J , Shipman, R., Rheinwald, J , Demetri, G., Minden, M., Housman, D E., and Haber, D. A. The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nat. Genet., 4: 415-420, 1993.